Adelaide Research & Scholarship: Search

Search

Results 31-40 of 60 (Search time: 0.004 seconds).

previous
1
2
3
4
5
6
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2005	Developing a relativities approach to valuing the prevention of non-fatal work-related accidents and ill health	Karnon, J.; Tsuchiya, A.; Dolan, P.
	2012	Applying risk adjusted cost-effectiveness (RAC-E) analysis to hospitals: estimating the costs and consequences of variation in clinical practice	Karnon, J.; Caffrey, O.; Pham, C.; Grieve, R.; Ben-Tovim, D.; Hakendorf, P.; Crotty, M.
	2015	Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility space	McCaffrey, N.; Agar, M.; Harlum, J.; Karnon, J.; Currow, D.; Eckermann, S.; Feenstra, T.
	2015	Cost-value analysis and the SAVE: a work in progress, but an option for localised decision making?	Karnon, J.; Partington, A.
	2012	Lifetime cost-utility analyses of deferasirox in beta-thalassaemia patients with chronic iron overload: A UK perspective	Karnon, J.; Tolley, K.; Vieira, J.; Chandiwana, D.
	2013	A risk-adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetes	Hajiali Afzali, H.; Gray, J.; Beilby, J.; Holton, C.; Banham, D.; Karnon, J.
	2007	Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature	Delea, T.; Karnon, J.; Goss, P.
	2001	A model for analyzing the cost of the main clinical events after lung transplantation	Sharples, L.; Taylor, G.; Karnon, J.; Caine, N.; Buxton, M.; McNeil, K.; Wallwork, J.
	2012	A model-based evaluation of collaborative care in management of patients with type 2 diabetes in Australia: an initial report	Hajiali Afzali, H.; Karnon, J.; Gray, J.; Beilby, J.
	2017	Costs of paying higher prices for equivalent effects on the Pharmaceutical Benefits Scheme	Karnon, J.; Edney, L.; Sorich, M.